{"disease":{"id":"rhinovirus","name":"rhinovirus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT07217639","title":"Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Aptitude Medical Systems","has_results":false},{"nct_id":"NCT03605862","title":"Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1756,"lead_sponsor_name":"Romark Laboratories L.C.","has_results":true},{"nct_id":"NCT04489381","title":"Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":214,"lead_sponsor_name":"Romark Laboratories L.C.","has_results":true},{"nct_id":"NCT07399132","title":"A Study of APL-10456-Vaccine","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"Apollo Therapeutics Ltd","has_results":false},{"nct_id":"NCT04670627","title":"Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics","phase":"","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT05016687","title":"First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Curovir AB","has_results":false},{"nct_id":"NCT06931002","title":"A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis","phase":"NA","overall_status":"RECRUITING","enrollment_count":54,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT06149494","title":"RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Altesa Biosciences, Inc.","has_results":false},{"nct_id":"NCT07112235","title":"Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT01159782","title":"Mechanisms of Rhinovirus Induced Asthma Exacerbations","phase":"NA","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Imperial College London","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}